| Trade name of the product: |
| Arranon |
| Pharmaceutical active ingredients: |
| Nelarabine |
| Available forms, composition and doses of Arranon: |
| Injectable; Infusion; Nelarabine 5 mg / ml |
| Medical categories: |
| Human:Cytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01BB07 - Nelarabine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Arranon: |
| Arranon prescribing information (PDF) |